Multiple sclerosis relapse |
1628.26 |
14.25 |
739 |
34330 |
41386 |
46609607 |
Urinary tract infection |
1302.61 |
14.25 |
1172 |
33897 |
219094 |
46431899 |
Gait disturbance |
1264.72 |
14.25 |
968 |
34101 |
144295 |
46506698 |
Laboratory test abnormal |
997.36 |
14.25 |
437 |
34632 |
22410 |
46628583 |
Multiple sclerosis |
859.88 |
14.25 |
404 |
34665 |
24387 |
46626606 |
Balance disorder |
697.22 |
14.25 |
491 |
34578 |
64030 |
46586963 |
Urine analysis abnormal |
596.84 |
14.25 |
191 |
34878 |
3999 |
46646994 |
Fall |
505.87 |
14.25 |
892 |
34177 |
328205 |
46322788 |
Therapy cessation |
384.53 |
14.25 |
243 |
34826 |
26386 |
46624607 |
Muscular weakness |
330.19 |
14.25 |
375 |
34694 |
91469 |
46559524 |
Seizure |
231.17 |
14.25 |
366 |
34703 |
122688 |
46528305 |
Insomnia |
209.37 |
14.25 |
413 |
34656 |
164511 |
46486482 |
Escherichia urinary tract infection |
205.74 |
14.25 |
116 |
34953 |
10207 |
46640786 |
Muscle spasticity |
199.89 |
14.25 |
118 |
34951 |
11322 |
46639671 |
Gait inability |
167.51 |
14.25 |
167 |
34902 |
35036 |
46615957 |
Rheumatoid arthritis |
165.60 |
14.25 |
3 |
35066 |
240212 |
46410781 |
Peroneal nerve palsy |
153.81 |
14.25 |
71 |
34998 |
4097 |
46646896 |
B-lymphocyte count decreased |
153.61 |
14.25 |
46 |
35023 |
764 |
46650229 |
Inappropriate schedule of product administration |
145.52 |
14.25 |
210 |
34859 |
64803 |
46586190 |
Dizziness |
139.21 |
14.25 |
564 |
34505 |
339850 |
46311143 |
Drug ineffective |
138.31 |
14.25 |
924 |
34145 |
676914 |
45974079 |
Central nervous system lesion |
136.83 |
14.25 |
87 |
34982 |
9528 |
46641465 |
Toxicity to various agents |
133.74 |
14.25 |
6 |
35063 |
211760 |
46439233 |
Secondary progressive multiple sclerosis |
131.17 |
14.25 |
45 |
35024 |
1175 |
46649818 |
Lymphocyte count decreased |
128.42 |
14.25 |
125 |
34944 |
25464 |
46625529 |
Therapeutic response unexpected |
128.29 |
14.25 |
101 |
34968 |
15515 |
46635478 |
Hypoaesthesia |
126.39 |
14.25 |
277 |
34792 |
118592 |
46532401 |
Culture urine positive |
125.87 |
14.25 |
58 |
35011 |
3333 |
46647660 |
Memory impairment |
120.88 |
14.25 |
212 |
34857 |
77125 |
46573868 |
Urine leukocyte esterase positive |
115.34 |
14.25 |
50 |
35019 |
2485 |
46648508 |
Dyspnoea |
106.73 |
14.25 |
139 |
34930 |
515409 |
46135584 |
Paraesthesia |
106.43 |
14.25 |
257 |
34812 |
117180 |
46533813 |
Flushing |
106.02 |
14.25 |
181 |
34888 |
64433 |
46586560 |
Mobility decreased |
101.08 |
14.25 |
171 |
34898 |
60423 |
46590570 |
Micturition urgency |
97.20 |
14.25 |
65 |
35004 |
7752 |
46643241 |
Anaemia |
96.19 |
14.25 |
36 |
35033 |
255743 |
46395250 |
Asthenia |
93.63 |
14.25 |
471 |
34598 |
310604 |
46340389 |
Pollakiuria |
90.27 |
14.25 |
101 |
34968 |
24160 |
46626833 |
Walking aid user |
85.11 |
14.25 |
50 |
35019 |
4750 |
46646243 |
Completed suicide |
80.82 |
14.25 |
8 |
35061 |
145912 |
46505081 |
JC polyomavirus test positive |
78.95 |
14.25 |
29 |
35040 |
928 |
46650065 |
T-lymphocyte count increased |
78.04 |
14.25 |
18 |
35051 |
98 |
46650895 |
Urinary incontinence |
77.10 |
14.25 |
101 |
34968 |
28429 |
46622564 |
Off label use |
76.84 |
14.25 |
104 |
34965 |
379737 |
46271256 |
Lymphopenia |
75.39 |
14.25 |
74 |
34995 |
15219 |
46635774 |
Head injury |
74.12 |
14.25 |
92 |
34977 |
24544 |
46626449 |
Acute kidney injury |
73.54 |
14.25 |
43 |
35026 |
235812 |
46415181 |
CD4 lymphocytes increased |
72.18 |
14.25 |
18 |
35051 |
143 |
46650850 |
T-lymphocyte count decreased |
71.67 |
14.25 |
20 |
35049 |
255 |
46650738 |
Progressive multiple sclerosis |
69.06 |
14.25 |
25 |
35044 |
767 |
46650226 |
Trigeminal neuralgia |
68.94 |
14.25 |
37 |
35032 |
2952 |
46648041 |
Neurogenic bladder |
64.27 |
14.25 |
35 |
35034 |
2875 |
46648118 |
Product substitution issue |
61.87 |
14.25 |
66 |
35003 |
14965 |
46636028 |
Motor dysfunction |
61.75 |
14.25 |
48 |
35021 |
7234 |
46643759 |
Dysstasia |
61.39 |
14.25 |
71 |
34998 |
17597 |
46633396 |
Depression |
59.31 |
14.25 |
269 |
34800 |
169835 |
46481158 |
Influenza like illness |
58.66 |
14.25 |
132 |
34937 |
57438 |
46593555 |
Red blood cells urine positive |
56.59 |
14.25 |
31 |
35038 |
2576 |
46648417 |
Neutropenia |
55.74 |
14.25 |
19 |
35050 |
143185 |
46507808 |
Hypotension |
54.07 |
14.25 |
57 |
35012 |
232532 |
46418461 |
White blood cells urine positive |
53.16 |
14.25 |
35 |
35034 |
4065 |
46646928 |
Exposure during pregnancy |
52.55 |
14.25 |
9 |
35060 |
108203 |
46542790 |
Pneumonia |
52.03 |
14.25 |
130 |
34939 |
376190 |
46274803 |
CD4 lymphocytes decreased |
51.94 |
14.25 |
25 |
35044 |
1585 |
46649408 |
CD8 lymphocytes decreased |
50.72 |
14.25 |
14 |
35055 |
171 |
46650822 |
Febrile neutropenia |
50.31 |
14.25 |
6 |
35063 |
94621 |
46556372 |
Dysgraphia |
49.28 |
14.25 |
29 |
35040 |
2763 |
46648230 |
Drug hypersensitivity |
48.97 |
14.25 |
67 |
35002 |
243758 |
46407235 |
Adverse drug reaction |
48.91 |
14.25 |
105 |
34964 |
44257 |
46606736 |
Diarrhoea |
48.03 |
14.25 |
237 |
34832 |
559365 |
46091628 |
Temperature intolerance |
47.51 |
14.25 |
42 |
35027 |
7565 |
46643428 |
Gait spastic |
47.00 |
14.25 |
14 |
35055 |
228 |
46650765 |
Epilepsy |
46.37 |
14.25 |
72 |
34997 |
23666 |
46627327 |
Product dose omission issue |
46.26 |
14.25 |
249 |
34820 |
168271 |
46482722 |
Loss of control of legs |
46.19 |
14.25 |
22 |
35047 |
1362 |
46649631 |
Dysuria |
44.34 |
14.25 |
77 |
34992 |
27756 |
46623237 |
Primary progressive multiple sclerosis |
44.26 |
14.25 |
11 |
35058 |
86 |
46650907 |
Lymphocyte count abnormal |
43.92 |
14.25 |
17 |
35052 |
630 |
46650363 |
Progressive multifocal leukoencephalopathy |
43.51 |
14.25 |
48 |
35021 |
11298 |
46639695 |
Gastrointestinal haemorrhage |
43.46 |
14.25 |
4 |
35065 |
77369 |
46573624 |
Haemoglobin urine present |
43.44 |
14.25 |
17 |
35052 |
649 |
46650344 |
Ataxia |
41.86 |
14.25 |
52 |
35017 |
13878 |
46637115 |
Escherichia test positive |
41.57 |
14.25 |
23 |
35046 |
1949 |
46649044 |
Arthralgia |
41.55 |
14.25 |
138 |
34931 |
364465 |
46286528 |
Movement disorder |
41.46 |
14.25 |
57 |
35012 |
16792 |
46634201 |
Full blood count abnormal |
40.95 |
14.25 |
21 |
35048 |
1526 |
46649467 |
Vomiting |
40.40 |
14.25 |
189 |
34880 |
452605 |
46198388 |
Burning sensation |
39.95 |
14.25 |
97 |
34972 |
44314 |
46606679 |
Vitamin B12 increased |
39.78 |
14.25 |
15 |
35054 |
517 |
46650476 |
Wheelchair user |
39.71 |
14.25 |
29 |
35040 |
3979 |
46647014 |
Drug interaction |
39.57 |
14.25 |
57 |
35012 |
203037 |
46447956 |
Magnetic resonance imaging abnormal |
39.53 |
14.25 |
25 |
35044 |
2711 |
46648282 |
Hemiparesis |
39.37 |
14.25 |
61 |
35008 |
20008 |
46630985 |
Pancytopenia |
39.32 |
14.25 |
8 |
35061 |
85050 |
46565943 |
Optic neuritis |
39.10 |
14.25 |
36 |
35033 |
6835 |
46644158 |
Abdominal pain |
38.79 |
14.25 |
71 |
34998 |
229960 |
46421033 |
Muscle spasms |
38.70 |
14.25 |
189 |
34880 |
122924 |
46528069 |
Nitrite urine present |
38.44 |
14.25 |
16 |
35053 |
718 |
46650275 |
Urine odour abnormal |
38.41 |
14.25 |
31 |
35038 |
4931 |
46646062 |
Pleural effusion |
37.93 |
14.25 |
8 |
35061 |
82944 |
46568049 |
Respiratory failure |
37.90 |
14.25 |
12 |
35057 |
94804 |
46556189 |
General symptom |
37.77 |
14.25 |
23 |
35046 |
2332 |
46648661 |
Systemic lupus erythematosus |
37.61 |
14.25 |
3 |
35066 |
65177 |
46585816 |
Urine abnormality |
37.18 |
14.25 |
32 |
35037 |
5562 |
46645431 |
Cognitive disorder |
36.92 |
14.25 |
84 |
34985 |
36799 |
46614194 |
Joint swelling |
34.99 |
14.25 |
44 |
35025 |
166029 |
46484964 |
Intentional overdose |
34.81 |
14.25 |
4 |
35065 |
64940 |
46586053 |
Generalised tonic-clonic seizure |
34.37 |
14.25 |
68 |
35001 |
27054 |
46623939 |
Urinary tract infection bacterial |
34.33 |
14.25 |
27 |
35042 |
4138 |
46646855 |
B-lymphocyte count abnormal |
34.32 |
14.25 |
8 |
35061 |
46 |
46650947 |
Feeling abnormal |
33.76 |
14.25 |
184 |
34885 |
124876 |
46526117 |
Cardiac arrest |
33.46 |
14.25 |
13 |
35056 |
90386 |
46560607 |
Prescribed underdose |
33.07 |
14.25 |
43 |
35026 |
12010 |
46638983 |
Urinary tract infection pseudomonal |
32.94 |
14.25 |
15 |
35054 |
838 |
46650155 |
Platelet count decreased |
32.92 |
14.25 |
17 |
35052 |
100007 |
46550986 |
Tremor |
32.47 |
14.25 |
172 |
34897 |
115467 |
46535526 |
Hyponatraemia |
32.21 |
14.25 |
18 |
35051 |
101314 |
46549679 |
Infusion related reaction |
32.14 |
14.25 |
18 |
35051 |
101190 |
46549803 |
Tongue biting |
31.78 |
14.25 |
17 |
35052 |
1347 |
46649646 |
Death |
31.72 |
14.25 |
137 |
34932 |
335411 |
46315582 |
Thrombocytopenia |
31.71 |
14.25 |
29 |
35040 |
126552 |
46524441 |
Acute disseminated encephalomyelitis |
31.65 |
14.25 |
10 |
35059 |
200 |
46650793 |
Musculoskeletal disorder |
31.55 |
14.25 |
48 |
35021 |
15497 |
46635496 |
Product use issue |
31.27 |
14.25 |
16 |
35053 |
94628 |
46556365 |
Fatigue |
30.58 |
14.25 |
633 |
34436 |
608064 |
46042929 |
Ankle fracture |
30.22 |
14.25 |
47 |
35022 |
15464 |
46635529 |
Lymphocyte percentage decreased |
30.13 |
14.25 |
21 |
35048 |
2678 |
46648315 |
Cystitis |
29.55 |
14.25 |
84 |
34985 |
42157 |
46608836 |
Extra dose administered |
29.42 |
14.25 |
26 |
35043 |
4681 |
46646312 |
Decreased appetite |
29.09 |
14.25 |
64 |
35005 |
193772 |
46457221 |
Blood immunoglobulin M decreased |
29.03 |
14.25 |
13 |
35056 |
698 |
46650295 |
Treatment failure |
28.92 |
14.25 |
17 |
35052 |
93070 |
46557923 |
Hypokinesia |
28.91 |
14.25 |
39 |
35030 |
11283 |
46639710 |
Insurance issue |
27.59 |
14.25 |
17 |
35052 |
1761 |
46649232 |
Bladder disorder |
27.24 |
14.25 |
30 |
35039 |
7048 |
46643945 |
Glycosylated haemoglobin increased |
27.07 |
14.25 |
37 |
35032 |
10839 |
46640154 |
Invasive ductal breast carcinoma |
27.01 |
14.25 |
28 |
35041 |
6140 |
46644853 |
Immune reconstitution inflammatory syndrome |
26.91 |
14.25 |
27 |
35042 |
5698 |
46645295 |
Coordination abnormal |
26.88 |
14.25 |
37 |
35032 |
10912 |
46640081 |
Psoriasis |
26.40 |
14.25 |
13 |
35056 |
78591 |
46572402 |
Overdose |
25.97 |
14.25 |
23 |
35046 |
101956 |
46549037 |
Hypoxia |
25.85 |
14.25 |
4 |
35065 |
51834 |
46599159 |
Pyrexia |
25.81 |
14.25 |
155 |
34914 |
348647 |
46302346 |
Contraindicated product administered |
25.70 |
14.25 |
14 |
35055 |
79933 |
46571060 |
Sinusitis |
25.67 |
14.25 |
36 |
35033 |
129732 |
46521261 |
Lymphocyte percentage abnormal |
25.49 |
14.25 |
5 |
35064 |
10 |
46650983 |
Cardiac failure congestive |
25.47 |
14.25 |
19 |
35050 |
91731 |
46559262 |
Status epilepticus |
25.36 |
14.25 |
41 |
35028 |
13938 |
46637055 |
Hyperkalaemia |
25.09 |
14.25 |
4 |
35065 |
50705 |
46600288 |
Weight increased |
24.92 |
14.25 |
54 |
35015 |
164419 |
46486574 |
Bacterial test positive |
24.86 |
14.25 |
23 |
35046 |
4393 |
46646600 |
International normalised ratio increased |
24.84 |
14.25 |
3 |
35066 |
46880 |
46604113 |
Urinary sediment present |
24.73 |
14.25 |
16 |
35053 |
1804 |
46649189 |
Product use in unapproved indication |
24.67 |
14.25 |
19 |
35050 |
90254 |
46560739 |
Asthma |
24.10 |
14.25 |
20 |
35049 |
91522 |
46559471 |
Maternal exposure during pregnancy |
23.94 |
14.25 |
25 |
35044 |
102524 |
46548469 |
Headache |
23.81 |
14.25 |
497 |
34572 |
477855 |
46173138 |
Paraparesis |
23.80 |
14.25 |
16 |
35053 |
1923 |
46649070 |
Tachycardia |
23.58 |
14.25 |
24 |
35045 |
99598 |
46551395 |
Plasma cell myeloma |
23.19 |
14.25 |
3 |
35066 |
44475 |
46606518 |
Rash |
23.04 |
14.25 |
165 |
34904 |
356347 |
46294646 |
Cardiac failure |
22.92 |
14.25 |
16 |
35053 |
79932 |
46571061 |
Oxygen saturation decreased |
22.39 |
14.25 |
12 |
35057 |
69152 |
46581841 |
Human papilloma virus test positive |
22.39 |
14.25 |
9 |
35060 |
369 |
46650624 |
Urine ketone body present |
22.36 |
14.25 |
16 |
35053 |
2126 |
46648867 |
Stress |
22.18 |
14.25 |
87 |
34982 |
51464 |
46599529 |
Lower respiratory tract infection |
21.96 |
14.25 |
7 |
35062 |
55082 |
46595911 |
Protein urine present |
21.95 |
14.25 |
23 |
35046 |
5108 |
46645885 |
Proteus test positive |
21.79 |
14.25 |
7 |
35062 |
148 |
46650845 |
Electrocardiogram QT prolonged |
21.41 |
14.25 |
6 |
35063 |
51319 |
46599674 |
Muscle tightness |
21.17 |
14.25 |
32 |
35037 |
10273 |
46640720 |
Renal failure |
21.02 |
14.25 |
33 |
35036 |
113561 |
46537432 |
Cystitis klebsiella |
21.00 |
14.25 |
7 |
35062 |
167 |
46650826 |
Incontinence |
20.79 |
14.25 |
31 |
35038 |
9831 |
46641162 |
Anaphylactic reaction |
20.73 |
14.25 |
7 |
35062 |
53105 |
46597888 |
Urinary tract infection enterococcal |
20.63 |
14.25 |
16 |
35053 |
2402 |
46648591 |
Skin laceration |
20.62 |
14.25 |
44 |
35025 |
18458 |
46632535 |
Relapsing-remitting multiple sclerosis |
20.54 |
14.25 |
9 |
35060 |
459 |
46650534 |
Diplopia |
20.32 |
14.25 |
45 |
35024 |
19360 |
46631633 |
Red blood cell count abnormal |
20.21 |
14.25 |
11 |
35058 |
902 |
46650091 |
Cardio-respiratory arrest |
19.96 |
14.25 |
10 |
35059 |
59859 |
46591134 |
Multiple organ dysfunction syndrome |
19.86 |
14.25 |
7 |
35062 |
51703 |
46599290 |
Hypoglycaemia |
19.80 |
14.25 |
8 |
35061 |
54341 |
46596652 |
Limb discomfort |
19.68 |
14.25 |
49 |
35020 |
22727 |
46628266 |
Feeling hot |
19.67 |
14.25 |
68 |
35001 |
37860 |
46613133 |
Disease progression |
19.41 |
14.25 |
24 |
35045 |
91276 |
46559717 |
Urinary retention |
19.38 |
14.25 |
53 |
35016 |
26008 |
46624985 |
Lower limb fracture |
19.35 |
14.25 |
34 |
35035 |
12364 |
46638629 |
Metabolic acidosis |
19.32 |
14.25 |
3 |
35066 |
38777 |
46612216 |
Rhabdomyolysis |
19.24 |
14.25 |
4 |
35065 |
41905 |
46609088 |
Stomatitis |
19.14 |
14.25 |
14 |
35055 |
68283 |
46582710 |
Initial insomnia |
19.12 |
14.25 |
20 |
35049 |
4432 |
46646561 |
Postictal paralysis |
19.02 |
14.25 |
5 |
35064 |
50 |
46650943 |
Hip fracture |
18.75 |
14.25 |
53 |
35016 |
26503 |
46624490 |
Bone pain |
18.62 |
14.25 |
6 |
35063 |
46884 |
46604109 |
Atrial fibrillation |
18.32 |
14.25 |
31 |
35038 |
103559 |
46547434 |
Ascites |
17.85 |
14.25 |
3 |
35066 |
36581 |
46614412 |
Urinary tract infection staphylococcal |
17.82 |
14.25 |
7 |
35062 |
270 |
46650723 |
Transferrin saturation decreased |
17.42 |
14.25 |
8 |
35061 |
456 |
46650537 |
Pain |
17.41 |
14.25 |
253 |
34816 |
476695 |
46174298 |
Blood thyroid stimulating hormone decreased |
17.27 |
14.25 |
18 |
35051 |
3971 |
46647022 |
Neuropathy peripheral |
17.20 |
14.25 |
26 |
35043 |
90867 |
46560126 |
Neutrophil percentage increased |
17.11 |
14.25 |
15 |
35054 |
2672 |
46648321 |
Oedema peripheral |
17.09 |
14.25 |
62 |
35007 |
159644 |
46491349 |
Sensory disturbance |
17.06 |
14.25 |
32 |
35037 |
12235 |
46638758 |
Decreased interest |
16.94 |
14.25 |
16 |
35053 |
3136 |
46647857 |
Postictal state |
16.72 |
14.25 |
10 |
35059 |
981 |
46650012 |
Bronchitis |
16.71 |
14.25 |
34 |
35035 |
105945 |
46545048 |
Chronic kidney disease |
16.64 |
14.25 |
5 |
35064 |
40866 |
46610127 |
Therapeutic response changed |
16.59 |
14.25 |
9 |
35060 |
733 |
46650260 |
Mean cell haemoglobin increased |
16.58 |
14.25 |
13 |
35056 |
1983 |
46649010 |
Bladder dysfunction |
16.53 |
14.25 |
9 |
35060 |
739 |
46650254 |
Migraine without aura |
16.51 |
14.25 |
6 |
35063 |
186 |
46650807 |
CD4 lymphocyte percentage decreased |
16.51 |
14.25 |
3 |
35066 |
3 |
46650990 |
Focal dyscognitive seizures |
16.45 |
14.25 |
15 |
35054 |
2813 |
46648180 |
Urge incontinence |
16.43 |
14.25 |
9 |
35060 |
748 |
46650245 |
Hepatic function abnormal |
16.40 |
14.25 |
3 |
35066 |
34418 |
46616575 |
Dehydration |
16.38 |
14.25 |
63 |
35006 |
159477 |
46491516 |
Infection |
16.26 |
14.25 |
49 |
35020 |
133543 |
46517450 |
Injection site scar |
16.17 |
14.25 |
9 |
35060 |
771 |
46650222 |
Mean cell haemoglobin decreased |
16.07 |
14.25 |
15 |
35054 |
2897 |
46648096 |
Weight decreased |
15.93 |
14.25 |
93 |
34976 |
210756 |
46440237 |
Dyspnoea exertional |
15.88 |
14.25 |
9 |
35060 |
50280 |
46600713 |
Breast cancer |
15.83 |
14.25 |
72 |
34997 |
45446 |
46605547 |
Suicide attempt |
15.79 |
14.25 |
11 |
35058 |
55025 |
46595968 |
Haematocrit abnormal |
15.78 |
14.25 |
9 |
35060 |
808 |
46650185 |
Depressed level of consciousness |
15.77 |
14.25 |
8 |
35061 |
47561 |
46603432 |
Cough |
15.62 |
14.25 |
105 |
34964 |
230144 |
46420849 |
Citrobacter infection |
15.56 |
14.25 |
7 |
35062 |
380 |
46650613 |
Vitamin D increased |
15.54 |
14.25 |
7 |
35062 |
381 |
46650612 |
Vitamin D decreased |
15.49 |
14.25 |
24 |
35045 |
7869 |
46643124 |
Glossodynia |
15.42 |
14.25 |
7 |
35062 |
44366 |
46606627 |
Urinary tract disorder |
15.16 |
14.25 |
13 |
35056 |
2247 |
46648746 |
General physical health deterioration |
15.16 |
14.25 |
41 |
35028 |
115728 |
46535265 |
Eye contusion |
15.14 |
14.25 |
11 |
35058 |
1497 |
46649496 |
Therapeutic product effect incomplete |
15.13 |
14.25 |
22 |
35047 |
78131 |
46572862 |
Coma |
15.04 |
14.25 |
13 |
35056 |
58336 |
46592657 |
Specific gravity urine abnormal |
14.98 |
14.25 |
3 |
35066 |
7 |
46650986 |
Hypokalaemia |
14.96 |
14.25 |
27 |
35042 |
87997 |
46562996 |
Pulmonary oedema |
14.95 |
14.25 |
10 |
35059 |
51095 |
46599898 |
Neutrophil count increased |
14.86 |
14.25 |
33 |
35036 |
14220 |
46636773 |
Arthritis |
14.74 |
14.25 |
22 |
35047 |
77294 |
46573699 |
Blood thyroid stimulating hormone increased |
14.66 |
14.25 |
20 |
35049 |
5849 |
46645144 |
Glucose urine present |
14.61 |
14.25 |
8 |
35061 |
664 |
46650329 |
B-lymphocyte count increased |
14.56 |
14.25 |
5 |
35064 |
131 |
46650862 |
Back pain |
14.54 |
14.25 |
230 |
34839 |
209809 |
46441184 |
Haematochezia |
14.53 |
14.25 |
5 |
35064 |
37488 |
46613505 |
Decreased vibratory sense |
14.38 |
14.25 |
6 |
35063 |
271 |
46650722 |